J B Chemicals & Pharmaceuticals Ltd EPS
J B Chemicals & Pharmaceuticals Ltd
NSE: JBCHEPHARM
EPS
Key Highlights
- The Earning per Share of J B Chemicals & Pharmaceuticals Ltd is ₹ 44.75 as of 11 Jun 26 The earning per share of J B Chemicals & Pharmaceuticals Ltd changed from ₹ 11.39 to ₹ 6.35 over 8 quarters. This represents a CAGR of -25.33% .
Historical Earning per Share of J B Chemicals & Pharmaceuticals Ltd
EPS, or Earnings Per Share, is a financial metric that represents the portion of a company's profit allocated to each outstanding share of common stock. It indicates a company's profitability and is calculated by dividing net income by the number of outstanding shares.
Historical Earning per Share of J B Chemicals & Pharmaceuticals Ltd
Company Fundamentals for J B Chemicals & Pharmaceuticals Ltd
Market Cap
36,308 Cr
EPS
44.8
P/E Ratio (TTM)
50.3
P/B Ratio (TTM)
8.7
Day’s High
2299.95
Day’s Low
2253.1
DTE
0.0
ROE
17.1
52 Week High
2299.95
52 Week Low
1603.05
ROCE
23.0
Market Price of J B Chemicals & Pharmaceuticals Ltd
1M
1Y
3Y
5Y
Last Ten Days Market Price
| Date | |
|---|---|
| 12 Jun 2026 | 2261.4 |
| 11 Jun 2026 | 2251.85 |
| 10 Jun 2026 | 2203.7 |
| 09 Jun 2026 | 2209.85 |
| 08 Jun 2026 | 2172.1 |
| 05 Jun 2026 | 2169.5 |
| 04 Jun 2026 | 2131.65 |
| 03 Jun 2026 | 2139.5 |
| 02 Jun 2026 | 2127.55 |
| 01 Jun 2026 | 2140.55 |
SWOT Analysis Of J B Chemicals & Pharmaceuticals Ltd
BlinkX Score for J B Chemicals & Pharmaceuticals Ltd
Asset Value vs Market Value of J B Chemicals & Pharmaceuticals Ltd
Market Value
₹ 36,155
Asset Value
Value addition
15.3 X
₹ 2,213
* All values are in ₹ crores
Competitive Comparison of EPS
| Company | Market Cap | EPS |
|---|
J B Chemicals & Pharmaceuticals Ltd | 36155 | 44.75 |
Sun Pharmaceutical Industries Ltd | 430513 | 52.01 |
Divis Laboratories Ltd | 176570 | 98.81 |
Torrent Pharmaceuticals Ltd | 154670 | 64.76 |
Cipla Ltd | 111725 | 47.12 |
Zydus Lifesciences Ltd | 111254 | 53.99 |
| Company | |
|---|---|
| J B Chemicals & Pharmaceuticals Ltd | 36155 |
| Sun Pharmaceutical Industries Ltd | 430513 |
| Divis Laboratories Ltd | 176570 |
| Torrent Pharmaceuticals Ltd | 154670 |
| Cipla Ltd | 111725 |
| Zydus Lifesciences Ltd | 111254 |
Historical Market Cap of J B Chemicals & Pharmaceuticals Ltd
Market Cap or market capitalisation refers to metrics that are used to measure a company's size. It is defined as the total market value of a company's outstanding shares of stock. Formula of Market Cap: Market Capital = N * P Here, N for the outstanding shares P refers to the closing price of the company's shares. Types of Companies based on Market Cap: - Small-Cap stocks: Up to 500 Crore - Mid-Cap Stocks: From Rs.500 crore up to Rs.7,000 crore - Large-Cap Stocks: From Rs.7,000 crore up to Rs.20,000 crore
Historical Market Cap of J B Chemicals & Pharmaceuticals Ltd
Historical Revenue of J B Chemicals & Pharmaceuticals Ltd
Revenue term means the amount of money a company earns from its primary business activities such as the sales of its products & services.\r\r\n\r\r\nTypes of Revenue:\r\r\n\r\r\n1. Operating revenue: It refers to the income generated from the core business activities, which are sales of goods or services rendered.\r\r\n\r\r\n2. Non-Operating revenue: It is the income generated from secondary sources unrelated to the primary business. Examples include rents, dividends, interest, and royalty fees.\r\r\n\r\r\nFormula for Revenue:\r\r\n\r\r\nThe formula for calculating revenue is based on two goods & services:\r\r\n\r\r\nFor goods:\r\r\nRevenue = Avg unit price x Number of Units sold\r\r\n\r\r\nFor services:\r\r\nRevenue = Avg unit price x Number of Customers served.
Historical Revenue of J B Chemicals & Pharmaceuticals Ltd
Historical EBITDA of J B Chemicals & Pharmaceuticals Ltd
PBIDT stands for Profit Before Interest, Depreciation, and Taxes. It is a financial metric that measures a company's profitability before accounting for interest expenses, depreciation of assets, and taxes. Formula to calculate PBIDT: PBIDT = Net Income + Interest + Depreciation + Taxes or PBIDT = Operating Income + Depreciation + Taxes PBIDT vs EBITDA vs EBIT vs EBT: Here is a brief explanation of the differences: - PBIDT (Profit Before Interest, Depreciation, and Taxes) includes taxes in its calculation, unlike EBITDA. - EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) excludes taxes and interest, focusing on operational performance. - EBIT (Earnings Before Interest and Taxes) excludes interest and taxes, providing a measure of core operational profitability. - EBT (Earnings Before Taxes) includes all operating income but does not account for interest expenses. Conclusion: PBIDT, similar to EBITDA, is a measure of operational profitability but includes taxes in its calculation.
Historical EBITDA of J B Chemicals & Pharmaceuticals Ltd
Historical Net Profit of J B Chemicals & Pharmaceuticals Ltd
Net profit is the amount of money a company retains after accounting for all expenses, depreciation, interest, taxes, and other deductions.\r\r\n\r\r\nNet Profit formula is expressed as:\r\r\n\r\r\nNet Profit = Total Revenue - Total Expense\r\r\n\r\r\nNet Profit Margin Ratio:\r\r\n\r\r\nNet Profit Margin Ratio = Net Profit / Total Revenue
Historical Net Profit of J B Chemicals & Pharmaceuticals Ltd
Dividend Payout Over Time
J B Chemicals & Pharmaceuticals Ltd News Hub
J B Chemicals & Pharmaceuticals Ltd soars 1.09%, Gains for third straight session
J B Chemicals & Pharmaceuticals Ltd is up for a third straight session in a row. The stock is quotin
Read more
14 Aug 24
J B Chemicals & Pharmaceuticals allots 11,500 equity shares under ESOS
J B Chemicals & Pharmaceuticals has allotted 11,500 equity shares under ESOS on 08 August 2024. Cons
Read more
08 Aug 24
J B Chemicals & Pharmaceuticals consolidated net profit rises 24.25% in the June 2024 quarter
Net profit of J B Chemicals & Pharmaceuticals rose 24.25% to Rs 176.83 crore in the quarter ended Ju
Read more
08 Aug 24
J B Chemicals & Pharmaceuticals allots 69,850 equity shares under ESOS
J B Chemicals & Pharmaceuticals has allotted 69,850 equity shares under ESOS on 26 August 2024. Cons
Read more
27 Aug 24
